Thus, we next sought to determine whether obesity-induced immunosuppression affects the efficacy of cancer immunotherapy or whether ICB therapy could potentially restore CD8 T cell function in obesity. The gene discussed is CD8A; the disease is obesity due to melanocortin 4 receptor deficiency.